Largest Biotechnology companies in Europe by Market Capitalization

This ranking features the largest 261 Biotechnology companies in Europe ranked by Market Capitalization, totaling a Market Capitalization of USD 1.80 T, for June 30, 2025.

#	Name	Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2 3 4 5 6

Frequently Asked Questions

Which Biotechnology company in Europe has the highest Market Capitalization ?

The Biotechnology company in Europe with the highest Market Capitalization is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 300.06 B.
Which Biotechnology company in Europe has the lowest Market Capitalization ?

The Biotechnology company in Europe with the lowest Market Capitalization is Fluicell AB (publ) (Stockholm Stock Exchange: FLUI.ST) at USD 1.34 M.

What are the top 10 Biotechnology companies in Europe by Market Capitalization ?

The top 10 Biotechnology companies in Europe by Market Capitalization are Novo Nordisk A/S, Roche Holding AG, Novartis AG, AstraZeneca PLC, Sanofi, GSK plc, Siemens Healthineers AG, MERCK Kommanditgesellschaft auf Aktien, Lonza Group AG and UCB SA.
What are the bottom 10 Biotechnology companies in Europe by Market Capitalization ?

The bottom 10 Biotechnology companies in Europe by Market Capitalization are Fluicell AB (publ), Aptahem AB (publ), Roquefort Therapeutics plc, Scandinavian Real Heart AB (Publ), Verici Dx plc, Scandinavian ChemoTech AB (publ), Biodexa Pharmaceuticals Plc, Modus Therapeutics Holding AB (publ), Prostatype Genomics AB (publ) and Qlife Holding AB (publ).